Key facts pulled from the official settlement site; not yet independently field-verified — confirm details on the official site.
Amylyx Pharmaceuticals Securities Settlement
Investors who purchased Amylyx Pharmaceuticals stock between November 2022 and November 2023 can claim compensation from a $6.5 million settlement over false statements about their ALS drug.
Gross average recovery approximately $0.24 per share; net average recovery approximately $0.16 per share after attorneys' fees, expenses, and service awards.
Who may qualify
You qualify if you purchased Amylyx Pharmaceuticals common stock between November 11, 2022 and November 8, 2023 and held shares during this period. Both individuals and entities can claim, and you must have suffered financial losses from the alleged misstatements.
All persons and entities who purchased or otherwise acquired Amylyx Pharmaceuticals Inc. securities between November 11, 2022, and November 8, 2023, inclusive, and suffered damages as a result.
This summary is based on available official settlement sources. The settlement administrator determines eligibility and payment approval.
Important dates
- Claim deadline
- August 31, 2026
- Exclusion deadline
- August 11, 2026
- Objection deadline
- August 11, 2026
Proof requirements
Proof requirement is currently marked as Yes.
Review the official claim form before submitting any information.
What you need
Claimants must provide Social Security or tax ID number, broker statements or confirmation slips documenting share purchases and sales, holdings as of November 10, 2022, and trading dates from November 11, 2022 through February 6, 2024.
How do I file a claim for this settlement?
File directly with Strategic Claims Services via the official claim form before August 31, 2026.
- Confirm you are within the eligible group described in the official notice — the settlement administrator determines eligibility.
- Gather any documents the official form asks for — this settlement marks proof as Yes.
- Open the official claim form or settlement website run by Strategic Claims Services.
- Submit accurate information through the official settlement administrator or government source before August 31, 2026.
- Save your confirmation number if one is provided, then watch the payment status for distribution updates.
New to settlement claims? How to file safely →
Worried it might be fake? Run the 60-second legitimacy check →
How we verified this record
- Claim deadline queued for re-check
- Payout details queued for re-check
- Eligibility queued for re-check
- Proof requirement queued for re-check
- Administrator queued for re-check
- Official claim link queued for re-check
- Court case queued for re-check
- Payment status queued for re-check
Every published record clears our source-verification bar; remaining fields are checked one by one on our weekly re-verification pass.
Checked fields are matched against a named official source and re-checked on a schedule. We show the authority and the date, never our internal evidence link.
Common questions
Who may qualify for this settlement?
All persons and entities who purchased or otherwise acquired Amylyx Pharmaceuticals Inc. securities between November 11, 2022, and November 8, 2023, inclusive, and suffered damages as a result.
What is the claim deadline?
The claim deadline is August 31, 2026. Confirm the current deadline on the official settlement source before filing.
Do I need proof to claim?
Proof requirement: Yes. The settlement administrator determines what documentation, if any, is required.
What is the current payment status?
Current payment status: Unknown. Payments are issued by the administrator after the court process concludes.
When will Amylyx Pharmaceuticals Securities Settlement pay out?
Current payment status: Unknown. Class-action payouts typically begin only after final approval and any appeals. See our payout timeline guide.
Where is the official Amylyx Pharmaceuticals Securities Settlement claim form?
The official claim form is hosted by the settlement administrator, Strategic Claims Services. Use the 'Open official claim form' button on this page — never pay a fee to file.
What did Amylyx lie about?
Amylyx made false or misleading statements about its ALS treatment Relyvrio's commercial prospects, hiding the fact that patients were discontinuing treatment early, new patient enrollment was declining, and prescription data was being withheld from analysts.
Do I need my original brokerage statements?
Yes, you must provide broker statements, confirmation slips, or other documentation showing your share purchases, sales, prices, and dates. You also need to report how many shares you held on November 10, 2022.
How much money will I get?
The average payout is about $0.16 per share after fees, but actual amounts depend on how many shares you owned and when you sold them. The settlement distributes $6.5 million total across all eligible claimants on a pro-rata basis.
What if I want to exclude myself from the settlement?
You can opt out by August 11, 2026, which means you give up the right to any settlement payment but preserve your right to sue individually. Otherwise, you're bound by the settlement terms once the court approves it.
Where to act
When you are ready, you open the official claim form yourself. SettleSignal does not file claims or determine eligibility.
Use the official settlement administrator or government source.
Listed on the official settlement website (Strategic Claims Services).
Disclaimer
This service summarizes publicly available settlement information and links to official settlement sources. We are not a law firm, do not provide legal advice, do not submit claims on your behalf, and do not determine eligibility or payout approval. Only file a claim if the information you provide is accurate.
Change log
- June 9, 2026 — Settlement published after verification.